Cannabis oil modulates liver alterations and endocannabinoid system changes in a female rat model of diet-induced MASLD

Autores
Degrave, Valentina; Vega Joubert, Michelle Berenice; Ingaramo, Paola I.; Sedan, Daniela Yazmine; Andrinolo, Darío; Mac Loughlin, Tomás Mariano; D’Alessandro, María Eugenia; Oliva, María Eugenia
Año de publicación
2026
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Introduction: Metabolic dysfunction–associated steatotic liver disease (MASLD) is closely linked to alterations in liver lipid metabolism, oxidative stress, fibrosis, and dysregulation of the endocannabinoid system (ECS). Although increasing evidence supports a role for cannabinoids in metabolic disorders, most preclinical studies have been conducted in male models, leaving female-specific responses largely unexplored. Methods: This study evaluated the effects of oral administration of a fullspectrum cannabis oil (CBD:THC 2:1) on MASLD-related alterations and ECS regulation in female Wistar rats fed a sucrose-rich diet (SRD). Rats were assigned to reference diet (RD), SRD, or SRD plus cannabis oil (1 mg/kg/day) for 3 weeks. Results: SRD-fed rats developed liver steatosis and increased NAFLD activity score (NAS), accompanied by enhanced de novo lipogenesis, reduced mitochondrial fatty acid oxidation, increased oxidative stress, early fibrotic changes, and ECS overactivation. Cannabis oil administration improved liver lipid metabolism, reduced NAS and fibrosis markers, attenuated lipid peroxidation and oxidative stress, increased NrF2 and decreased NF-κB p65 expression, and normalized hepatic CB1 expression and circulating endocannabinoid levels. Discussion: These findings demonstrate that full-spectrum cannabis oil is associated with improved MASLD-related outcomes and modulation of ECS tone in a female-specific model of diet-induced metabolic liver disease.
Centro de Investigaciones del Medioambiente
Materia
Salud
Biología
Cannabidiol (CBD)
Cannabis oil
Endocannabinod system
MASLD
Metabolic syndrome
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by/4.0/
Repositorio
SEDICI (UNLP)
Institución
Universidad Nacional de La Plata
OAI Identificador
oai:sedici.unlp.edu.ar:10915/193452

id SEDICI_a8f864823a33c2c1c392ae3a5c2cf690
oai_identifier_str oai:sedici.unlp.edu.ar:10915/193452
network_acronym_str SEDICI
repository_id_str 1329
network_name_str SEDICI (UNLP)
spelling Cannabis oil modulates liver alterations and endocannabinoid system changes in a female rat model of diet-induced MASLDDegrave, ValentinaVega Joubert, Michelle BereniceIngaramo, Paola I.Sedan, Daniela YazmineAndrinolo, DaríoMac Loughlin, Tomás MarianoD’Alessandro, María EugeniaOliva, María EugeniaSaludBiologíaCannabidiol (CBD)Cannabis oilEndocannabinod systemMASLDMetabolic syndromeIntroduction: Metabolic dysfunction–associated steatotic liver disease (MASLD) is closely linked to alterations in liver lipid metabolism, oxidative stress, fibrosis, and dysregulation of the endocannabinoid system (ECS). Although increasing evidence supports a role for cannabinoids in metabolic disorders, most preclinical studies have been conducted in male models, leaving female-specific responses largely unexplored. Methods: This study evaluated the effects of oral administration of a fullspectrum cannabis oil (CBD:THC 2:1) on MASLD-related alterations and ECS regulation in female Wistar rats fed a sucrose-rich diet (SRD). Rats were assigned to reference diet (RD), SRD, or SRD plus cannabis oil (1 mg/kg/day) for 3 weeks. Results: SRD-fed rats developed liver steatosis and increased NAFLD activity score (NAS), accompanied by enhanced de novo lipogenesis, reduced mitochondrial fatty acid oxidation, increased oxidative stress, early fibrotic changes, and ECS overactivation. Cannabis oil administration improved liver lipid metabolism, reduced NAS and fibrosis markers, attenuated lipid peroxidation and oxidative stress, increased NrF2 and decreased NF-κB p65 expression, and normalized hepatic CB1 expression and circulating endocannabinoid levels. Discussion: These findings demonstrate that full-spectrum cannabis oil is associated with improved MASLD-related outcomes and modulation of ECS tone in a female-specific model of diet-induced metabolic liver disease.Centro de Investigaciones del Medioambiente2026-03-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdf1770150-1770150https://doi.org/10.3389/fnut.2026.1770150http://sedici.unlp.edu.ar/handle/10915/193452enginfo:eu-repo/semantics/altIdentifier/url/https://public-pages-files-2025.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1770150/pdfinfo:eu-repo/semantics/altIdentifier/issn/2296-861Xinfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/4.0/Creative Commons Attribution 4.0 International (CC BY 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2026-04-28T14:02:57Zoai:sedici.unlp.edu.ar:10915/193452Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292026-04-28 14:02:57.535SEDICI (UNLP) - Universidad Nacional de La Platafalse
dc.title.none.fl_str_mv Cannabis oil modulates liver alterations and endocannabinoid system changes in a female rat model of diet-induced MASLD
title Cannabis oil modulates liver alterations and endocannabinoid system changes in a female rat model of diet-induced MASLD
spellingShingle Cannabis oil modulates liver alterations and endocannabinoid system changes in a female rat model of diet-induced MASLD
Degrave, Valentina
Salud
Biología
Cannabidiol (CBD)
Cannabis oil
Endocannabinod system
MASLD
Metabolic syndrome
title_short Cannabis oil modulates liver alterations and endocannabinoid system changes in a female rat model of diet-induced MASLD
title_full Cannabis oil modulates liver alterations and endocannabinoid system changes in a female rat model of diet-induced MASLD
title_fullStr Cannabis oil modulates liver alterations and endocannabinoid system changes in a female rat model of diet-induced MASLD
title_full_unstemmed Cannabis oil modulates liver alterations and endocannabinoid system changes in a female rat model of diet-induced MASLD
title_sort Cannabis oil modulates liver alterations and endocannabinoid system changes in a female rat model of diet-induced MASLD
dc.creator.none.fl_str_mv Degrave, Valentina
Vega Joubert, Michelle Berenice
Ingaramo, Paola I.
Sedan, Daniela Yazmine
Andrinolo, Darío
Mac Loughlin, Tomás Mariano
D’Alessandro, María Eugenia
Oliva, María Eugenia
author Degrave, Valentina
author_facet Degrave, Valentina
Vega Joubert, Michelle Berenice
Ingaramo, Paola I.
Sedan, Daniela Yazmine
Andrinolo, Darío
Mac Loughlin, Tomás Mariano
D’Alessandro, María Eugenia
Oliva, María Eugenia
author_role author
author2 Vega Joubert, Michelle Berenice
Ingaramo, Paola I.
Sedan, Daniela Yazmine
Andrinolo, Darío
Mac Loughlin, Tomás Mariano
D’Alessandro, María Eugenia
Oliva, María Eugenia
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Salud
Biología
Cannabidiol (CBD)
Cannabis oil
Endocannabinod system
MASLD
Metabolic syndrome
topic Salud
Biología
Cannabidiol (CBD)
Cannabis oil
Endocannabinod system
MASLD
Metabolic syndrome
dc.description.none.fl_txt_mv Introduction: Metabolic dysfunction–associated steatotic liver disease (MASLD) is closely linked to alterations in liver lipid metabolism, oxidative stress, fibrosis, and dysregulation of the endocannabinoid system (ECS). Although increasing evidence supports a role for cannabinoids in metabolic disorders, most preclinical studies have been conducted in male models, leaving female-specific responses largely unexplored. Methods: This study evaluated the effects of oral administration of a fullspectrum cannabis oil (CBD:THC 2:1) on MASLD-related alterations and ECS regulation in female Wistar rats fed a sucrose-rich diet (SRD). Rats were assigned to reference diet (RD), SRD, or SRD plus cannabis oil (1 mg/kg/day) for 3 weeks. Results: SRD-fed rats developed liver steatosis and increased NAFLD activity score (NAS), accompanied by enhanced de novo lipogenesis, reduced mitochondrial fatty acid oxidation, increased oxidative stress, early fibrotic changes, and ECS overactivation. Cannabis oil administration improved liver lipid metabolism, reduced NAS and fibrosis markers, attenuated lipid peroxidation and oxidative stress, increased NrF2 and decreased NF-κB p65 expression, and normalized hepatic CB1 expression and circulating endocannabinoid levels. Discussion: These findings demonstrate that full-spectrum cannabis oil is associated with improved MASLD-related outcomes and modulation of ECS tone in a female-specific model of diet-induced metabolic liver disease.
Centro de Investigaciones del Medioambiente
description Introduction: Metabolic dysfunction–associated steatotic liver disease (MASLD) is closely linked to alterations in liver lipid metabolism, oxidative stress, fibrosis, and dysregulation of the endocannabinoid system (ECS). Although increasing evidence supports a role for cannabinoids in metabolic disorders, most preclinical studies have been conducted in male models, leaving female-specific responses largely unexplored. Methods: This study evaluated the effects of oral administration of a fullspectrum cannabis oil (CBD:THC 2:1) on MASLD-related alterations and ECS regulation in female Wistar rats fed a sucrose-rich diet (SRD). Rats were assigned to reference diet (RD), SRD, or SRD plus cannabis oil (1 mg/kg/day) for 3 weeks. Results: SRD-fed rats developed liver steatosis and increased NAFLD activity score (NAS), accompanied by enhanced de novo lipogenesis, reduced mitochondrial fatty acid oxidation, increased oxidative stress, early fibrotic changes, and ECS overactivation. Cannabis oil administration improved liver lipid metabolism, reduced NAS and fibrosis markers, attenuated lipid peroxidation and oxidative stress, increased NrF2 and decreased NF-κB p65 expression, and normalized hepatic CB1 expression and circulating endocannabinoid levels. Discussion: These findings demonstrate that full-spectrum cannabis oil is associated with improved MASLD-related outcomes and modulation of ECS tone in a female-specific model of diet-induced metabolic liver disease.
publishDate 2026
dc.date.none.fl_str_mv 2026-03-10
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Articulo
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://doi.org/10.3389/fnut.2026.1770150
http://sedici.unlp.edu.ar/handle/10915/193452
url https://doi.org/10.3389/fnut.2026.1770150
http://sedici.unlp.edu.ar/handle/10915/193452
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://public-pages-files-2025.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1770150/pdf
info:eu-repo/semantics/altIdentifier/issn/2296-861X
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by/4.0/
Creative Commons Attribution 4.0 International (CC BY 4.0)
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0/
Creative Commons Attribution 4.0 International (CC BY 4.0)
dc.format.none.fl_str_mv application/pdf
1770150-1770150
dc.source.none.fl_str_mv reponame:SEDICI (UNLP)
instname:Universidad Nacional de La Plata
instacron:UNLP
reponame_str SEDICI (UNLP)
collection SEDICI (UNLP)
instname_str Universidad Nacional de La Plata
instacron_str UNLP
institution UNLP
repository.name.fl_str_mv SEDICI (UNLP) - Universidad Nacional de La Plata
repository.mail.fl_str_mv alira@sedici.unlp.edu.ar
_version_ 1863817606074466304
score 13.039539